Evidence map›Paper›PMID 28289028›Full record

ArticleAntimicrobial agents and chemotherapy2017

Assessment and Optimizations of Candida albicans

Matthew B Lohse, Megha Gulati, Ashley Valle Arevalo, Adam Fishburn, Alexander D Johnson, Clarissa J Nobile

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Effect of Mn(II) and Co(II) on Anti-Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Efficacy of calcium hypochlorite in disinfection of gutta-percha cones contaminated with Candida albicans.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  11. Journal of fungi (Basel, Switzerland) · 2023
    Article
  12. Alterations in the Level of Ergosterol inInternational journal of molecular sciences · 2023
    Article
  13. Anti-Metabolites · 2022
    Article
  14. VaginalMicroorganisms · 2022
    Article
  15. Activity ofNanomaterials (Basel, Switzerland) · 2022
    Article
  16. Characterization ofFrontiers in molecular biosciences · 2022
    Article
  17. Article
  18. Augmenting the Activity of Chlorhexidine for Decolonization ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew B LohseDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.
Megha GulatiDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, California, USA.
Ashley Valle ArevaloDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, California, USA.
Adam FishburnDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, California, USA.
Alexander D JohnsonDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.
Clarissa J NobileDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, California, USA cnobile@ucmerced.edu.
University of California, Merced · USUniversity of California, San Francisco · US

Funding

The transcriptional circuitry controlling biofilm development in Candida albicansR01AI083311 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSON, ALEXANDER D · 2011 to 2020
$4.3M
Genetic Analysis of the Transcriptional Network Governing C. albicans BiofilmsR00AI100896 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI NOBILE, CLARISSA JANE · 2014 to 2015
$498k
Development of Therapeutics to Treat Candida albicans Biofilm InfectionsR41AI112038 · NIAID · BIOSYNESIS, INC. · PI NOBILE, CLARISSA JANE · 2015 to 2015
$225k
NIAID NIH HHS R00 AI100896NIAID NIH HHS R01 AI083311NIAID NIH HHS R41 AI112038
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsBiofilmsCandida albicansCandidiasisCaspofunginCell AdhesionEchinocandinsHumansLipopeptidesMicrobial Sensitivity TestsMicrofluidicsProsthesis-Related InfectionsAntifungal AgentsCaspofunginEchinocandinsLipopeptidesbiofilmbiofilm methodsbiofilm protocolsbiofilm screensCandida albicansin vitro biofilm assays

Identifiers

PMID28289028
PMCPMC5404589
OpenAlexW2596463476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.